Arjona José E, Miño Mónica, Cordón Javier, Povedano Balbino, Pelegrin Blas, Castelo-Branco Camil
Department of Gynecology and Obstetrics, Hysteroscopy Unit, Reina Sofía University Hospital, Cordoba, Spain.
Fertil Steril. 2008 Oct;90(4):1182-6. doi: 10.1016/j.fertnstert.2007.08.007. Epub 2008 Jan 16.
To evaluate women's satisfaction and tolerance of hysteroscopic sterilization.
Prospective analysis of case series.
Gynecology department in a teaching hospital.
PATIENT(S): A total of 1,630 women who underwent hysteroscopic sterilization by placement of Essure microinserts (Conceptus, Inc., Mountain View, CA) from January 2003 to June 2006.
INTERVENTION(S): Transvaginal ultrasound examination, pelvic x-ray examination, and hysterosalpingography 3 months after sterilization with Essure microinserts. Satisfaction was assessed by a visual analog scale. Adverse effects and tolerance also were recorded.
MAIN OUTCOME MEASURE(S): Transvaginal ultrasound and pelvic x-ray confirmation of correct localization of microinserts and patient's satisfaction and tolerance after a 3-month follow-up.
RESULT(S): The rate of successful insertion was 99%. Most of women returned to their daily activities on the same day of insertion, and 86.5% considered the procedure painless or scarcely painful. All the patients were highly satisfied after hysteroscopic sterilization: 91% of subjects by visual analog scale (on a 0 to 10 scale) rated the method at 10 (high satisfaction degree), and none of the subjects rated it under 8. For patients, the most valuable aspects of the procedure were absence of surgery room (52.7%), method's quickness and comfort (19.9%), and permanent sterilization (18.2%). More than 97% of the patients said that they would recommend the procedure to others.
CONCLUSION(S): This study provides evidence that Essure microinserts can be placed in a usual gynecologic consultation room in standard conditions without any type of anesthesia or sedation and are associated with great overall patient satisfaction. Women also have high tolerance for the procedure and describe minor postoperative pain.
评估女性对宫腔镜绝育术的满意度和耐受性。
病例系列的前瞻性分析。
一家教学医院的妇科。
2003年1月至2006年6月期间共1630名接受了通过放置埃苏瑞微插入物(Conceptus公司,加利福尼亚州山景城)进行宫腔镜绝育术的女性。
使用埃苏瑞微插入物绝育术后3个月进行经阴道超声检查、盆腔X光检查和子宫输卵管造影。通过视觉模拟量表评估满意度。记录不良反应和耐受性。
经阴道超声和盆腔X光确认微插入物定位正确以及3个月随访后患者的满意度和耐受性。
成功插入率为99%。大多数女性在插入当天就恢复了日常活动,86.5%的女性认为该手术无痛或几乎无痛。所有患者在宫腔镜绝育术后都非常满意:91%的受试者通过视觉模拟量表(0至10分)将该方法评为10分(高满意度),且没有受试者评分低于8分。对患者来说,该手术最有价值的方面是无需手术室(52.7%)、手术快速舒适(19.9%)和永久绝育(18.2%)。超过97%的患者表示会向他人推荐该手术。
本研究提供的证据表明,埃苏瑞微插入物可在标准条件下于普通妇科诊室放置,无需任何类型的麻醉或镇静,且总体患者满意度很高。女性对该手术也有较高的耐受性,术后疼痛轻微。